See the DrugPatentWatch profile for Cyclophosphamide
The generic name for cyclophosphamide is cyclophosphamide. It is an alkylating agent used in chemotherapy to treat various cancers, including lymphomas, multiple myeloma, and leukemias, as well as certain autoimmune diseases [1].
What conditions does cyclophosphamide treat?
Cyclophosphamide is prescribed for a range of medical conditions. Its applications in cancer treatment include Hodgkin's lymphoma, non-Hodgkin's lymphoma, chronic lymphocytic leukemia, chronic myelogenous leukemia, acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma [1]. Beyond oncology, it is used to manage severe autoimmune disorders such as lupus nephritis, rheumatoid arthritis, and granulomatosis with polyangiitis [2].
How does cyclophosphamide work?
As an alkylating agent, cyclophosphamide functions by interfering with DNA replication and cell division [1]. It is a prodrug that requires activation by enzymes in the liver to become cytotoxic. Once activated, it forms cross-links between DNA strands, preventing the cancer cells from dividing and ultimately leading to their death [3].
When did cyclophosphamide become available?
Cyclophosphamide was first synthesized in the early 1950s and was introduced clinically shortly thereafter [4]. Its long history in medicine means it has been widely studied and is a well-established treatment option.
What are the side effects of cyclophosphamide?
Common side effects associated with cyclophosphamide treatment can include nausea, vomiting, hair loss, and a decrease in blood cell counts (leukopenia, thrombocytopenia, anemia) [1]. More serious potential side effects involve damage to the bladder (hemorrhagic cystitis), which can be mitigated by adequate hydration and administration of mesna [3]. It can also affect fertility and has a risk of causing secondary cancers in the long term [1].
Are there different formulations of cyclophosphamide?
Cyclophosphamide is available in oral tablet form and as a powder for injection, which is reconstituted before administration [1]. These different formulations allow for flexibility in treatment delivery depending on the patient's needs and the specific medical indication.
Where can I find information on cyclophosphamide patents?
Information regarding patents for cyclophosphamide and its related treatments can be found through resources like DrugPatentWatch.com [5]. This site tracks patent filings, expiry dates, and legal challenges, which can be crucial for understanding market exclusivity and the potential for generic or biosimilar competition.
Who manufactures generic cyclophosphamide?
Multiple pharmaceutical companies manufacture generic versions of cyclophosphamide. The availability of generic options contributes to making the treatment more accessible [1].
What is the regulatory status of cyclophosphamide?
Cyclophosphamide is an approved medication by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and is listed on the World Health Organization's List of Essential Medicines [1, 6]. Its long-standing approval indicates a well-established safety and efficacy profile for its indicated uses.
How does cyclophosphamide compare to other chemotherapy drugs?
Cyclophosphamide belongs to the nitrogen mustard class of alkylating agents. It differs from other chemotherapy classes, such as antimetabolites, anthracyclines, or taxanes, in its mechanism of action. While all chemotherapy drugs aim to kill rapidly dividing cells, the specific molecular targets and side effect profiles vary significantly between drug classes and individual agents [7]. Its use is often part of combination chemotherapy regimens tailored to specific cancer types.
What are the risks of cyclophosphamide treatment for patients?
Patients undergoing cyclophosphamide therapy face risks including increased susceptibility to infections due to immunosuppression, potential for infertility, and long-term risks such as the development of other cancers [1]. Careful monitoring by healthcare professionals is essential to manage these risks and address any adverse events promptly.
Can cyclophosphamide be used in combination therapy?
Yes, cyclophosphamide is frequently used as part of combination chemotherapy regimens for various cancers. It is often combined with other agents like vincristine and prednisone (e.g., in COP chemotherapy) or doxorubicin, etoposide, and prednisone (e.g., in CHOP chemotherapy) to enhance treatment efficacy [8].
Sources:
- Cyclophosphamide. National Institute of Health, National Cancer Institute.
- Cyclophosphamide. Mayo Clinic.
- Cyclophosphamide Injection. MedlinePlus.
- The history of cyclophosphamide. PubMed Central.
- DrugPatentWatch.com
- WHO Model List of Essential Medicines. World Health Organization.
- Chemotherapy Drugs. National Cancer Institute.
- Lymphoma Chemotherapy Regimens. American Cancer Society.